Skip to content
healthcare.dev
Get a free key

EMROSI

NDC 69489-131, Minocycline Hydrochloride Extended-Release, capsule, from Journey Medical Corporation.

Product NDC
69489-131
Status
Listed
Labeler
Journey Medical Corporation
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219015
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69489-131 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MINOCYCLINE HYDROCHLORIDE40 mg/1

Pharmacologic classes

Decreased Prothrombin Activity [PE]; Tetracycline-class Drug [EPC]; Tetracyclines [CS]

Package NDCNDC-11Package
69489-131-07694890131077 CAPSULE in 1 BOTTLE (69489-131-07)
69489-131-306948901313030 CAPSULE in 1 BOTTLE (69489-131-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0899eb25-8807-037c-f66c-141a2696b1c0

Use it

Look up 69489-131 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69489-131 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69489-131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.